Multi-center, Observational Registry with Retrospective Enrollment and Prospective Follow-up. The aim of the registry is to document the feasibility and safety of implanting an Edwards SAPIEN XT transcatheter heart valve in the pulmonic position.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
right ventricular and pulmonary artery pressure
Timeframe: 30 days
max flow velocity RVOT
Timeframe: 30 days
NYHA class
Timeframe: 30 days
degree of pulmonary regurgitation
Timeframe: 30 days
procedural success
Timeframe: 30 days
Peak gradient
Timeframe: 30 days
length of hospitalization
Timeframe: 30 days
Peak Oxygen consumption
Timeframe: 24 months
anaerobic threshold
Timeframe: 24 months
device function
Timeframe: 24 months
structural valve Deterioration including stent fracture
Timeframe: 24 months